|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-2-24
|
|
pubmed:abstractText |
The Val34Leu mutation in the activation peptide of factor XIII (FXIIIA) correlates with a lower incidence of myocardial infarction and ischemic stroke but an increased risk for hemorrhagic stroke. We describe mass spectrometric detection of the activation peptide variants in human serum.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0009-9147
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
545-51
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14726471-Adult,
pubmed-meshheading:14726471-Chromatography, High Pressure Liquid,
pubmed-meshheading:14726471-Factor VIII,
pubmed-meshheading:14726471-Humans,
pubmed-meshheading:14726471-Leucine,
pubmed-meshheading:14726471-Male,
pubmed-meshheading:14726471-Mass Spectrometry,
pubmed-meshheading:14726471-Peptide Fragments,
pubmed-meshheading:14726471-Peptides,
pubmed-meshheading:14726471-Phenotype,
pubmed-meshheading:14726471-Polymorphism, Genetic,
pubmed-meshheading:14726471-Proteomics,
pubmed-meshheading:14726471-Spectrometry, Mass, Matrix-Assisted Laser...,
pubmed-meshheading:14726471-Valine
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Mass spectrometric phenotyping of Val34Leu polymorphism of blood coagulation factor XIII by differential peptide display.
|
|
pubmed:affiliation |
BioVisioN AG, Hannover, Germany. h.tammen@biovision-discovery.de
|
|
pubmed:publicationType |
Journal Article
|
